Watchlist Price Alert

Ultragenyx Pharmaceutical... (RARE)

NASDAQ: RARE · Real-Time Price · USD

36.61

-0.50 (-1.35%)

At close: Jun 17, 2025, 12:28 PM

Ultragenyx Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-569.18M	-606.64M	-707.42M	-454.02M	-186.57M	-402.73M	-197.61M	-302.14M	-245.87M
Depreciation & Amortization	35.54M	26.01M	18.22M	13.24M	12.26M	8.54M	19.54M	5.83M	3.42M
Stock-Based Compensation	158.03M	135.21M	130.38M	104.95M	85.73M	82M	80.11M	68.01M	48.31M
Other Working Capital	n/a	12.23M	-5.44M	-57.49M	66.57M	-12.04M	-15.3M	-23.69M	23.8M
Other Non-Cash Items	-52.5M	-12.67M	119.76M	11.71M	21.46M	1.69M	-156K	10.93M	700K
Deferred Income Tax	n/a	-1.62M	-1.64M	48.67M	-169.78M	-18.94M	-167.65M	-16.25M	6.16M
Change in Working Capital	n/a	-15.1M	60.23M	-63.24M	104.66M	-15.94M	-24.79M	-20.23M	26.3M
Operating Cash Flow	-414.19M	-474.81M	-380.46M	-338.69M	-132.22M	-345.38M	-290.57M	-253.84M	-160.97M
Capital Expenditures	-7.49M	-46.77M	-146.12M	-73.09M	-43.91M	-24.83M	-4.08M	-2.79M	-10.19M
Cash Acquisitions	n/a	n/a	-75.03M	n/a	n/a	-11.79M	n/a	-142.8M	n/a
Purchase of Investments	-408.61M	-526.38M	-614.74M	-1.01B	-850.3M	-707.16M	-509.8M	-230.49M	-442.49M
Sales Maturities Of Investments	413.27M	746.2M	545.08M	890.85M	720.64M	718.96M	310.22M	431.57M	543.79M
Other Investing Acitivies	-14.94M	-7.55M	-844K	-942K	-5.55M	11.79M	170.32M	934K	-1.2M
Investing Cash Flow	-17.77M	168M	-291.65M	-195.37M	-179.12M	-13.04M	-33.33M	56.42M	89.92M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.94M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	18.26M	8.39M	501.21M	39.61M	89.06M	324.06M	27.83M	9.25M	59.19M
Financial Cash Flow	399.24M	388.14M	501.21M	118.55M	600.27M	679.31M	336.85M	136.27M	138.68M
Net Cash Flow	-35.24M	81.8M	-171.98M	-416.71M	290.05M	320.72M	12.48M	-60.63M	67.55M
Free Cash Flow	-421.68M	-521.57M	-526.59M	-411.79M	-176.13M	-370.21M	-294.64M	-256.64M	-171.16M